To scale for recent exponential growth, the project aimed for transforming the client’s automation platform by implementing a global modular approach covering all products at all sites. The delivered a successful improvement in time-to-market and reduced lead times for technology transfers.

Global pharmaceutical company facing large growth was looking to optimise capacity of own manufacturing sites and CMOs to address increasing demand as well as new therapy areas. Planning processes were defined for S&OP, tactical planning and operation planning enabling increased capacity utilisation as well as stock coverage.

Global pharmaceutical company looking to integrate large portfolio of products and supply chains into existing setup, without jeopardizing short-term sales. Integration covered CMO's, manufacturing sites and distribution in more than 80 countries while handling substantial changes to regulatory approvals as well as packaging materials and labels.

The company were struggling with recurrent performance issues and an inability to support future growth projections. The project aimed to identify a sustainable way to grow and operate the future QC departments by enabling the existing organisation to absorb additional growth. 

By applying the Implement QC assessment framework immediate optimisation levers solution were developed delivering an increasing in QC +30%.

Global Pharmaceutical company wanted an assessment of where to place a future manufacturing campus. Evaluation of multiple regions in Europe and US. Labor availability, cost and supply chain fit among the criteria being evaluated.

The strategy aimed to include comprehensive greenhouse gas (GHG) emission data collection throughout the value chain, long-term objectives, strategic focus areas, roadmaps for scope 1, 2, and 3 emissions, significant milestones, and an implementation plan for both EU and US markets.

We helped a company introduce modularisation and copy/paste thinking across three overlapping expansion projects. 

A programme was established to ensure alignment of design, planning and project execution. We played a key role in facilitating dialogue, resulting in an aligned programme strategy that was executed in the individual projects. 

The programme resulted in significant reductions in effort hours, construction time and design complexity

We helped a company that invested more than USD 2 billion in a new US biopharmaceutical manufacturing site to boost bio-CDMO (contract development and manufacturing organization) growth. 

This site aims to become the largest end-to-end cell culture CDMO provider in North America. Through the PMO, Implement led key activities such as design facilitation, warehouse sizing, workforce planning, operational readiness planning and establishing the new business entity

A medical device company needed to increase capacity by 50% while maintaining existing production.

Together with the client, we established a project to create a conceptual design (CD) for the expansion of the existing facility.

We bridged many different areas of expertise and stakeholders, facilitating the process and co-creating the resulting report. The CD report included an initial strategic evaluation of six different solutions, warehouse sizing, design of material and personnel flow, layout, business case, timeline, budget and risks.

With multiple major expansions in the drug substance business, the company faced operational readiness challenges within a tight time frame. A dedicated operational readiness project organisation was established to implement a detailed execution process for fast ramp-up.

Simultaneously, the future business unit operating model was defined, outlining core standardisation requirements for equipment, technology, processes and procedures to maximise product allocation and capacity utilisation.

The project delivered impact by facilitating strategic decision-making and increasing project management capabilities. Implement facilitated the process of resolving strategic issues and challenged direction setting as a trusted advisor. 

Key contributions included: 

- Preparing and implementing a project cockpit to track progress

- Reviewing and implementing a project-wide meeting structure, reporting cadence and escalation route 

- Facilitating and executing several large-scale events (250+ people) 

- Implementing a new approach to risk and mitigation planning

A biotechnology company was experiencing consistent growth due to increased demand for its current products and anticipated new product launches in the future. 

Prompted by expansion and employee turnover, there was a need for improved structure, governance and process optimisation. 

We helped develop a new operating model to ensure operational consistency and to embed knowledge in roles rather than individuals. This enabled a culture of continuous improvement, a decrease in the number of incidents and an increase in employee satisfaction.

The client created a capacity master plan to ensure delivery of new products to patients. Implement established and operated the PMO for a manufacturing expansion project to deliver on this capacity plan.

Key roles taken by Implement included:

- PMO lead and team

- Procurement lead

- Subject matter expert advisory and support on specific tracks

- Facilitation and project management of specific tracks

The team provided support from the conceptual brief until the client was able to take over the roles in basic design. 

The project was highlighted internally as a best-practice example.

A large global pharmaceutical manufacturer set out to expand capacity with multiple production lines across multiple sites within a record-breaking time frame. 

The team helped set up the central project PMO and establish core discipline practices, such as organisational design, risk management, schedule management, cost management and communication strategies. 

The practices were adapted through basic and detailed design using Half Double principles to accommodate increasing complexity, asynchronous timelines between sites and a project organisation that grew tenfold over the two-year engagement.